3 Stocks Dragging The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 4 points (0.0%) at 16,511 as of Wednesday, April 23, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,718 issues advancing vs. 1,280 declining with 133 unchanged.

The Health Services industry currently sits down 0.4% versus the S&P 500, which is down 0.1%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. St Jude Medical ( STJ) is one of the companies pushing the Health Services industry lower today. As of noon trading, St Jude Medical is down $0.73 (-1.2%) to $62.21 on heavy volume. Thus far, 2.0 million shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $61.93-$63.06 after having opened the day at $62.87 as compared to the previous trading day's close of $62.94.

St. Jude Medical, Inc. develops, manufactures and distributes medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. St Jude Medical has a market cap of $17.8 billion and is part of the health care sector. Shares are up 1.6% year-to-date as of the close of trading on Tuesday. Currently there are 14 analysts that rate St Jude Medical a buy, 1 analyst rates it a sell, and 6 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, reasonable valuation levels and solid stock price performance. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full St Jude Medical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Intuitive Surgical ( ISRG) is down $41.08 (-9.7%) to $381.25 on heavy volume. Thus far, 1.4 million shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 571,700 shares. The stock has ranged in price between $378.43-$397.40 after having opened the day at $387.20 as compared to the previous trading day's close of $422.33.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $15.8 billion and is part of the health care sector. Shares are up 10.0% year-to-date as of the close of trading on Tuesday. Currently there are 8 analysts that rate Intuitive Surgical a buy, 5 analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Intuitive Surgical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Thermo Fisher Scientific ( TMO) is down $2.35 (-1.9%) to $118.00 on heavy volume. Thus far, 2.7 million shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2.6 million shares. The stock has ranged in price between $114.53-$121.77 after having opened the day at $121.71 as compared to the previous trading day's close of $120.35.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics in the United States and internationally. Thermo Fisher Scientific has a market cap of $47.6 billion and is part of the health care sector. Shares are up 8.1% year-to-date as of the close of trading on Tuesday. Currently there are 13 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Thermo Fisher Scientific Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

P&G Buys Consumer Healthcare Unit From Germany's Merck in First Peltz-era Deal

P&G Buys Consumer Healthcare Unit From Germany's Merck in First Peltz-era Deal

Amazon's Stock Spikes After Jeff Bezos Says He Has 100 Million Prime Members

Amazon's Stock Spikes After Jeff Bezos Says He Has 100 Million Prime Members

Oil Prices Soaring to $100 Makes These 4 Stocks Winners

Oil Prices Soaring to $100 Makes These 4 Stocks Winners

Amazon, Procter & Gamble, Southwest and Netflix - 5 Things You Must Know

Amazon, Procter & Gamble, Southwest and Netflix - 5 Things You Must Know

Global Stocks Mixed as Oil, Commodity Price Surges Ignite Fresh Inflation Talk

Global Stocks Mixed as Oil, Commodity Price Surges Ignite Fresh Inflation Talk